Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Avian Flu”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Early research (Phase 1)Study completedNCT00309647
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline 400
Testing effectiveness (Phase 2)Study completedNCT00719043
What this trial is testing

Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years

Who this might be right for
Influenza
GlaxoSmithKline 841
Early research (Phase 1)Study completedNCT01258062
What this trial is testing

Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults

Who this might be right for
Phase 1 Safety Study of GelVac Nasal Powder H5N1 Influenza Vaccine
Alachua Government Services, Inc. 7
Testing effectiveness (Phase 2)Study completedNCT05874713
What this trial is testing

Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults

Who this might be right for
Influenza, HumanInfectionsRespiratory Tract Infections+2 more
Seqirus 480
Testing effectiveness (Phase 2)Study completedNCT00884182
What this trial is testing

Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children

Who this might be right for
InfluenzaOrthomyxoviridae InfectionsOrthomyxovirus Infections
Sanofi Pasteur, a Sanofi Company 350
Post-approval studies (Phase 4)Study completedNCT03701061
What this trial is testing

Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response

Who this might be right for
Influenza A Subtype H5N1 Infection
Emory University 12
Not applicableStudy completedNCT01044095
What this trial is testing

Study of Seasonal Influenza Vaccine Against H5N1 Avian Influenza Virus

Who this might be right for
Influenza
Armed Forces Research Institute of Medical Sciences, Thailand 26
Early research (Phase 1)Enrolling By InvitationNCT07215871
What this trial is testing

Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 Influenza

Who this might be right for
Influenza InfectionInfectionsRespiratory Virus Infections+4 more
National Institute of Allergy and Infectious Diseases (NIAID) 33
Testing effectiveness (Phase 2)Study completedNCT00311675
What this trial is testing

St. Jude Open Label H5 Trial

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 35
Early research (Phase 1)Study completedNCT05436444
What this trial is testing

Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model

Who this might be right for
Influenza Infection
National Institute of Allergy and Infectious Diseases (NIAID) 35
Early research (Phase 1)Study completedNCT01656356
What this trial is testing

Phase I Safety and Immunogenicity of Live Attenuated Influenza H5 Candidate Vaccine Strain A/17/Turkey/Turkey/05/133 (H5N2) in Healthy Thai Volunteers

Who this might be right for
Preventive Avian Flu
Mahidol University
Early research (Phase 1)Study completedNCT01999842
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline 424
Testing effectiveness (Phase 2)Study completedNCT02680002
What this trial is testing

Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant

Who this might be right for
A/Vietnam/H5N1 Influenza Virus
Biomedical Advanced Research and Development Authority 422
Early research (Phase 1)Study completedNCT02480101
What this trial is testing

Reactogenicity, Safety and Immunogenicity of a LAIV H7N9 Influenza Vaccine

Who this might be right for
Influenza
Research Institute of Influenza, Russia 40